Open AccessPPARA polymorphism influences the cardiovascular benefit of fenofibrate in type 2 diabetes: Findings from accord-lipid
Author(s) -
M.L. Morieri,
H.S. Shah,
J. Sjaarda,
P.A. Lenzini,
H. Campbell,
A.A. Motsinger-Reif,
H. Gao,
L. Lovato,
S. Prudente,
A. Pandolfi,
M.G. Pezzolesi,
R.J. Sigal,
G. Paré,
S.M. Marcovina,
D.M. Rotroff,
E. Patorno,
L. Mercuri,
V. Trischitta,
E.Y. Chew,
P. Kraft,
J.B. Buse,
M.J. Wagner,
S. Cresci,
H.C. Gerstein,
H.N. Ginsberg,
J.C. Mychaleckyj,
A. Doria
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7pzq-3r48
Subject(s) - fenofibrate , type 2 diabetes , polymorphism (computer science) , medicine , endocrinology , diabetes mellitus , chemistry , biochemistry , gene , genotype